Medmix Ltd
SIX:MEDX
Cash Flow Statement
Cash Flow Statement
Medmix Ltd
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
44
|
45
|
12
|
(5)
|
1
|
(1)
|
(6)
|
(5)
|
|
| Depreciation & Amortization |
52
|
51
|
51
|
52
|
58
|
62
|
62
|
59
|
|
| Other Non-Cash Items |
21
|
19
|
49
|
42
|
12
|
9
|
18
|
29
|
|
| Cash Taxes Paid |
8
|
9
|
11
|
9
|
8
|
8
|
10
|
7
|
|
| Cash Interest Paid |
8
|
7
|
7
|
7
|
6
|
10
|
13
|
15
|
|
| Change in Working Capital |
(29)
|
(49)
|
(64)
|
(52)
|
(15)
|
(1)
|
14
|
5
|
|
| Cash from Operating Activities |
87
N/A
|
66
-25%
|
48
-28%
|
37
-23%
|
56
+54%
|
69
+23%
|
87
+25%
|
89
+2%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(32)
|
(30)
|
(39)
|
(46)
|
(53)
|
(55)
|
(49)
|
(45)
|
|
| Other Items |
29
|
(1)
|
(18)
|
(12)
|
(28)
|
(34)
|
(3)
|
(4)
|
|
| Cash from Investing Activities |
(3)
N/A
|
(31)
-842%
|
(57)
-83%
|
(58)
-2%
|
(81)
-38%
|
(89)
-10%
|
(52)
+42%
|
(49)
+4%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
288
|
282
|
(6)
|
(1)
|
(3)
|
(3)
|
(1)
|
(1)
|
|
| Net Issuance of Debt |
(136)
|
(197)
|
137
|
(11)
|
(134)
|
34
|
(33)
|
(57)
|
|
| Cash Paid for Dividends |
(41)
|
(15)
|
(15)
|
(8)
|
(15)
|
(15)
|
(15)
|
(15)
|
|
| Other |
1
|
0
|
0
|
0
|
(2)
|
0
|
0
|
(2)
|
|
| Cash from Financing Activities |
112
N/A
|
71
-36%
|
116
+63%
|
(20)
N/A
|
(154)
-681%
|
15
N/A
|
(49)
N/A
|
(75)
-55%
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(1)
|
1
|
(5)
|
|
| Net Change in Cash |
195
N/A
|
104
-47%
|
104
0%
|
(45)
N/A
|
(183)
-304%
|
(5)
+97%
|
(13)
-155%
|
(41)
-225%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
55
N/A
|
36
-35%
|
9
-75%
|
(10)
N/A
|
3
N/A
|
14
+347%
|
38
+166%
|
43
+13%
|
|